Cargando…
Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis
CONTEXT: Styrax is used for prevention and treatment of cerebrovascular diseases. However, the underlying mechanism remains unclear. OBJECTIVE: To elucidate styrax’s anti-ischemic stroke protective effects and underlying mechanisms. MATERIALS AND METHODS: An ischemic-stroke rat model was established...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461497/ https://www.ncbi.nlm.nih.gov/pubmed/37621078 http://dx.doi.org/10.1080/13880209.2023.2246501 |
_version_ | 1785097851613741056 |
---|---|
author | Mu, Fei Lin, Rui Lu, Xueyan Zhao, Meina Zhao, Jiaxin Huang, Shaojie Guo, Chao Guan, Yue Zhang, Haiyue Xi, Miaomiao Wang, Jingwen Tang, Haifeng |
author_facet | Mu, Fei Lin, Rui Lu, Xueyan Zhao, Meina Zhao, Jiaxin Huang, Shaojie Guo, Chao Guan, Yue Zhang, Haiyue Xi, Miaomiao Wang, Jingwen Tang, Haifeng |
author_sort | Mu, Fei |
collection | PubMed |
description | CONTEXT: Styrax is used for prevention and treatment of cerebrovascular diseases. However, the underlying mechanism remains unclear. OBJECTIVE: To elucidate styrax’s anti-ischemic stroke protective effects and underlying mechanisms. MATERIALS AND METHODS: An ischemic-stroke rat model was established based on middle cerebral artery occlusion (MCAO). Sprague-Dawley rats were randomly assigned to the following groups (n = 10) and administered intragastrically once a day for 7 consecutive days: sham, model, nimodipine (24 mg/kg), styrax-L (0.1 g/kg), styrax-M (0.2 g/kg) and styrax-H (0.4 g/kg). Neurological function, biochemical assessment, and ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS)-based serum metabonomics were used to elucidate styrax’s cerebral protective effects and mechanisms. Pearson correlation and western blot analyses were performed to verify. RESULTS: The addition of 0.4 g/kg styrax significantly reduced cerebral infarct volume and neurobehavioral abnormality score. Different doses of styrax also decrease MDA, TNF-α, IL-6, and IL-1β, and increase SOD and GSH-Px in ischemic-stroke rats (p < 0.05; MDA, p < 0.05 only at 0.4 g/kg dose). Biochemical indicators and metabolic-profile analyses (PCA, PLS-DA, and OPLS-DA) also supported styrax’s protective effects. Endogenous metabolites (22) were identified in ischemic-stroke rats, and these perturbations were reversible via styrax intervention, which is predominantly involved in energy metabolism, glutathione and glutamine metabolism, and other metabolic processes. Additionally, styrax significantly upregulated phosphorylated AMP-activated protein kinase and glutaminase brain-tissue expression. CONCLUSION: Styrax treatment could ameliorate ischemic-stroke rats by intervening with energy metabolism and glutamine metabolism. This can help us understand the mechanism of styrax, inspiring more clinical application and promotion. |
format | Online Article Text |
id | pubmed-10461497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-104614972023-08-29 Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis Mu, Fei Lin, Rui Lu, Xueyan Zhao, Meina Zhao, Jiaxin Huang, Shaojie Guo, Chao Guan, Yue Zhang, Haiyue Xi, Miaomiao Wang, Jingwen Tang, Haifeng Pharm Biol Research Article CONTEXT: Styrax is used for prevention and treatment of cerebrovascular diseases. However, the underlying mechanism remains unclear. OBJECTIVE: To elucidate styrax’s anti-ischemic stroke protective effects and underlying mechanisms. MATERIALS AND METHODS: An ischemic-stroke rat model was established based on middle cerebral artery occlusion (MCAO). Sprague-Dawley rats were randomly assigned to the following groups (n = 10) and administered intragastrically once a day for 7 consecutive days: sham, model, nimodipine (24 mg/kg), styrax-L (0.1 g/kg), styrax-M (0.2 g/kg) and styrax-H (0.4 g/kg). Neurological function, biochemical assessment, and ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS)-based serum metabonomics were used to elucidate styrax’s cerebral protective effects and mechanisms. Pearson correlation and western blot analyses were performed to verify. RESULTS: The addition of 0.4 g/kg styrax significantly reduced cerebral infarct volume and neurobehavioral abnormality score. Different doses of styrax also decrease MDA, TNF-α, IL-6, and IL-1β, and increase SOD and GSH-Px in ischemic-stroke rats (p < 0.05; MDA, p < 0.05 only at 0.4 g/kg dose). Biochemical indicators and metabolic-profile analyses (PCA, PLS-DA, and OPLS-DA) also supported styrax’s protective effects. Endogenous metabolites (22) were identified in ischemic-stroke rats, and these perturbations were reversible via styrax intervention, which is predominantly involved in energy metabolism, glutathione and glutamine metabolism, and other metabolic processes. Additionally, styrax significantly upregulated phosphorylated AMP-activated protein kinase and glutaminase brain-tissue expression. CONCLUSION: Styrax treatment could ameliorate ischemic-stroke rats by intervening with energy metabolism and glutamine metabolism. This can help us understand the mechanism of styrax, inspiring more clinical application and promotion. Taylor & Francis 2023-08-24 /pmc/articles/PMC10461497/ /pubmed/37621078 http://dx.doi.org/10.1080/13880209.2023.2246501 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Research Article Mu, Fei Lin, Rui Lu, Xueyan Zhao, Meina Zhao, Jiaxin Huang, Shaojie Guo, Chao Guan, Yue Zhang, Haiyue Xi, Miaomiao Wang, Jingwen Tang, Haifeng Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis |
title | Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis |
title_full | Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis |
title_fullStr | Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis |
title_full_unstemmed | Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis |
title_short | Protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by UPLC-Q/TOF-MS analysis |
title_sort | protective effect and mechanism of styrax on ischemic stroke rats: metabonomic insights by uplc-q/tof-ms analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461497/ https://www.ncbi.nlm.nih.gov/pubmed/37621078 http://dx.doi.org/10.1080/13880209.2023.2246501 |
work_keys_str_mv | AT mufei protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT linrui protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT luxueyan protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT zhaomeina protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT zhaojiaxin protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT huangshaojie protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT guochao protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT guanyue protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT zhanghaiyue protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT ximiaomiao protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT wangjingwen protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis AT tanghaifeng protectiveeffectandmechanismofstyraxonischemicstrokeratsmetabonomicinsightsbyuplcqtofmsanalysis |